<DOC>
	<DOC>NCT02028156</DOC>
	<brief_summary>This is a non-randomized, single-group, multi-center, two phased study to evaluate formula intolerance.</brief_summary>
	<brief_title>Feeding Intolerance in Formula-Fed Infants</brief_title>
	<detailed_description />
	<criteria>Inclusion Criteria for Stage 1: Singleton full term birth with birth weight of &gt; 2500g. Infant between 0 and 60 days of age. Discontinuation of medications that might affect gastrointestinal (GI) tolerance. Infant is exclusively formulafed a fulllactose, intact cow milk proteinbased infant formula (CMF) for less than 7 days prior to enrollment. Inclusion Criteria for Stage 2: Infant was fed according to protocol in Stage 1 of the study. Infant was identified as being fussy using the Intolerance Assessment Tool in Stage 1. Exclusion Criteria for Stage 1: Chromosomal or major congenital anomalies. Suspected or known metabolic or physical diseases affecting infant feeding and/or metabolism. Hospitalization, other than for delivery, prior to enrollment. Severe uncontrolled eczema, visible bloody stools or milk protein allergy prior to enrollment. More than 1 substitution of an infant formula other than fulllactose, intact cow milk formula (CMF) since birth. Use of a prokinetic drug within 7 days before enrollment. Exclusion Criteria for Stage 2: Infant's intolerance symptom was caused by another reason, for example known infection/illness, food allergy, or response to vaccination(s). Infant has immunization(s) within 3 days of enrollment in Stage 2.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>60 Days</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>